Salvage treatment using carbon ion radiation in patients with locoregionally recurrent nasopharyngeal carcinoma: Initial results

Reirradiation for locoregionally recurrent nasopharyngeal carcinoma (NPC) after a definitive dose of radiotherapy (RT) is challenging and usually associated with severe toxicities. Intensity‐modulated carbon ion RT (IMCT) offers physical/biologic advantages over photon‐based intensity‐modulated RT. Herein, the authors report their initial experience of IMCT in previously irradiated patients with locoregionally recurrent NPC.

• Publication year

  2018

• Venue

  Cancer

• Publication date

  2018-03-26

• Fields of study

  Medicine, Engineering

• Identifiers
  DOI 10.1002/cncr.31318PMID 29579324PMCID 6001443
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Proton therapy for nasopharyngeal carcinoma.

  2016cited by this paper
• Phase I/II trial evaluating concurrent carbon-ion radiotherapy plus chemotherapy for salvage treatment of locally recurrent nasopharyngeal carcinoma

  2016cited by this paper
• Reirradiation of locally recurrent nasopharyngeal cancer: history, advances, and promises for the future.

  2016cited by this paper
• Salvage Intensity-Modulated Radiation Therapy (IMRT) for Locally Recurrent Nasopharyngeal Cancer after Definitive IMRT: A Novel Scenario of the Modern Era

  2016cited by this paper
• Long-term outcomes of a phase II randomized controlled trial comparing intensity-modulated radiotherapy with or without weekly cisplatin for the treatment of locally recurrent nasopharyngeal carcinoma

  2016cited by this paper
• Advances in systemic treatment for nasopharyngeal carcinoma.

  2016influential reference
• Phase I/II Trial Evaluating Carbon Ion Radiotherapy for Salvaging Treatment of Locally Recurrent Nasopharyngeal Carcinoma

  2016cited by this paper
• Chemotherapy for Nasopharyngeal Carcinoma - Current Recommendation and Controversies.

  2015cited by this paper
• Management of Nasopharyngeal Carcinoma: Current Practice and Future Perspective.

  2015cited by this paper
• A Simpler Energy Transfer Efficiency Model to Predict Relative Biological Effect for Protons and Heavier Ions

  2015cited by this paper
• Skull Base and Upper Cervical Spine Tumors

  2014influential reference
• Ultrahigh dose-rate FLASH irradiation increases the differential response between normal and tumor tissue in mice

  2014cited by this paper
• Long‐term survival analysis of nasopharyngeal carcinoma by plasma Epstein‐Barr virus DNA levels

  2013cited by this paper
• Intensity-modulated radiation therapy for nasopharyngeal carcinoma: a review

  2012cited by this paper
• Long-term treatment outcome of recurrent nasopharyngeal carcinoma treated with salvage intensity modulated radiotherapy.

  2012cited by this paper
• Intensity-modulated radiation therapy in the salvage of locally recurrent nasopharyngeal carcinoma.

  2012cited by this paper
• Long-term outcomes and prognostic factors of re-irradiation for locally recurrent nasopharyngeal carcinoma using intensity-modulated radiotherapy.

  2012cited by this paper
• Adjuvant chemotherapy in advanced nasopharyngeal carcinoma based on plasma EBV load

  2012cited by this paper
• Emerging applications of stereotactic body radiation therapy for head and neck cancer

  2011cited by this paper
• Carbon ion radiotherapy performed as re-irradiation using active beam delivery in patients with tumors of the brain, skull base and sacral region.

  2011cited by this paper
• Current treatment options for recurrent nasopharyngeal cancer

  2010cited by this paper
• New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).

  2009cited by this paper
• Comparative study of dose distribution between carbon ion radiotherapy and photon radiotherapy for head and neck tumor

  2008cited by this paper
• Accuracy of the local effect model for the prediction of biologic effects of carbon ion beams in vitro and in vivo.

  2008cited by this paper
• Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma.

  2004cited by this paper
• Tissue tolerance to reirradiation.

  2000cited by this paper
• Nasopharyngeal carcinoma: repeat treatment with conformal proton therapy--dose-volume histogram analysis.

  1999cited by this paper
• Reirradiation for recurrent nasopharyngeal carcinoma: factors affecting the therapeutic ratio and ways for improvement.

  1997cited by this paper
• Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)

  1995cited by this paper
• Recurrent locally advanced nasopharyngeal carcinoma treated with heavy charged particle irradiation.

  1992cited by this paper
• Tolerance of normal tissue to therapeutic irradiation.

  1991cited by this paper
• Development of a hospital-based proton beam treatment center.

  1988cited by this paper
• Re-irradiation of recurrent nasopharyngeal carcinoma--treatment techniques and results.

  1987cited by this paper

• Programmed cell death in nasopharyngeal carcinoma: Mechanisms and therapeutic targets.

  2025cites this paper
• Outcomes and recurrence pattern analysis of intensity modulated chemoradiotherapy in nasopharyngeal cancer: a retrospective study from Heidelberg University Hospital

  2025cites this paper
• Upright positioning enhances beam angle optimization and organ sparing in head and neck carbon-ion radiotherapy with fixed-beam systems

  2025cites this paper
• Predictive biomarkers for immunotherapy in nasopharyngeal carcinoma: from tumor microenvironment to macroenvironment

  2025cites this paper
• A future directions of renal cell carcinoma treatment: combination of immune checkpoint inhibition and carbon ion radiotherapy

  2024cites this paper
• Asparaginase and isoaspartyl peptidase 1 RNA interference suppresses the growth of nasopharyngeal carcinoma cells

  2024cites this paper
• Research Progress of Traditional Drug Therapies for Nasopharyngeal Carcinoma by the PI3K/AKT Signaling Pathway

  2024cites this paper
• Interconnected influences of tumour and host microbiota on treatment response and side effects in nasopharyngeal cancer.

  2024cites this paper
• International Recommendations on Postoperative Management for Potentially Resectable Locally Recurrent Nasopharyngeal Carcinoma.

  2024cites this paper
• Tumor volume instead of recurrent T category predicts clinical outcome of patients with locally recurrent nasopharyngeal carcinoma salvaged by carbon ion radiation therapy.

  2024cites this paper
• A protocol for a randomized trial evaluating the role of carbon‐ion radiation therapy plus camrelizumab for patients with locoregionally recurrent nasopharyngeal carcinoma

  2024cites this paper
• Efficacy and safety of PLDR‐IMRT for the re‐irradiation of recurrent NPC: A prospective, single‐arm, multicenter trial

  2023cites this paper
• CACA guidelines for holistic integrative management of nasopharyngeal carcinoma

  2023cites this paper
• Robotic stereotactic body radiotherapy for recurrent nasopharyngeal carcinoma

  2023cites this paper
• Reirradiation of head and neck squamous cell carcinomas: a pragmatic approach, part II: radiation technique and fractionations

  2023cites this paper
• Identifying the prognostic value of MRI-based tumor response and predicting the risk of radio-resistance in re-radiotherapy for locally recurrent nasopharyngeal carcinoma.

  2023cites this paper
• Retreatment of Recurrent or Second Primary Head and Neck Cancer After Prior Radiation: Executive Summary of the American Radium Society® (ARS) Appropriate Use Criteria (AUC): Expert Panel on Radiation Oncology - Head and Neck Cancer.

  2022cites this paper
• Recurrence risk stratification based on Epstein–Barr virus DNA to identify enlarged retropharyngeal lymph nodes of nasopharyngeal carcinoma: A model-histopathologic correlation study

  2022cites this paper
• Treatment of Recurrent Nasopharyngeal Carcinoma: A Sequential Challenge

  2022cites this paper
• Particle beam therapy for nasopharyngeal cancer: A systematic review and meta-analysis

  2022influential citation
• Emerging Role of Carbon Ion Radiotherapy in Reirradiation of Recurrent Head and Neck Cancers: What Have We Achieved So Far?

  2022cites this paper
• Cost-Effectiveness analysis of combining plasma Epstein-Barr virus DNA testing and different surveillance imaging modalities for nasopharyngeal carcinoma patients in first remission.

  2022cites this paper
• Flourish of Proton and Carbon Ion Radiotherapy in China

  2022cites this paper
• Biological opportunities for personalized radiotherapy of nasopharyngeal carcinoma

  2021cites this paper
• Targeting the PD-1/ PD-L1 interaction in nasopharyngeal carcinoma.

  2021cites this paper
• Carbon ion triggered immunogenic necroptosis of nasopharyngeal carcinoma cells involving necroptotic inhibitor BCL-x

  2021cites this paper
• International Recommendations on Re-irradiation by Intensity-modulated Radiotherapy for Locally Recurrent Nasopharyngeal Carcinoma.

  2021cites this paper
• Re-irradiation with Moderate Hypo-fractionation Using Intensity Modulated Photon or Proton Radiation Therapy in Locally Recurrent Squamous Cell Carcinoma of Nasopharynx

  2021cites this paper
• Pretreatment 18F-FDG uptake heterogeneity can predict treatment outcome of carbon ion radiotherapy in patients with locally recurrent nasopharyngeal carcinoma

  2021cites this paper
• Retreatment in locally recurrent nasopharyngeal carcinoma: Current status and perspectives

  2021cites this paper
• Particle Beam Radiation Therapy for Nasopharyngeal Cancer

  2021cites this paper
• Advances in pathogenesis and precision medicine for nasopharyngeal carcinoma

  2021cites this paper
• Salvage Radiation Therapy for Locally Recurrent Nasopharyngeal Cancer

  2021cites this paper
• Nasopharyngeal carcinoma: an evolving paradigm

  2021cites this paper
• Application of Carbon Ion and Its Sensitizing Agent in Cancer Therapy: A Systematic Review

  2021cites this paper
• A Systematic Review on Re-irradiation with Charged Particle Beam Therapy in the Management of Locally Recurrent Skull Base and Head and Neck Tumors

  2021cites this paper
• Mixed Photon and Carbon-Ion Beam Radiotherapy in the Management of Non-Metastatic Nasopharyngeal Carcinoma

  2021cites this paper
• Ion therapy guideline (Version 2020)

  2021cites this paper
• Liquid biopsy posttreatment surveillance in endemic nasopharyngeal carcinoma: a cost-effective strategy to integrate circulating cell-free Epstein-Barr virus DNA

  2021cites this paper
• Dosimetric comparison of intensity modulated radiotherapy and intensity modulated proton therapy in the treatment of recurrent nasopharyngeal carcinoma.

  2021cites this paper
• Outcomes of Recurrent Nasopharyngeal Carcinoma Patients Treated With Salvage Surgery: A Meta-Analysis

  2021cites this paper
• Preliminary Safety and Efficacy of Proton Plus Carbon-Ion Radiotherapy With Concurrent Chemotherapy in Limited-Stage Small Cell Lung Cancer

  2021cites this paper
• Chinese ion therapy guideline (Version 2020)

  2021cites this paper
• Proton theraPy sPecial feature: review article re- irradiation with protons or heavy ions with focus on head and neck, skull base and brain malignancies

  2020cites this paper
• Fluorescent hollow mesoporous carbon spheres for drug loading and tumor treatment through 980-nm laser and microwave co-irradiation.

  2020cites this paper
• Prognostic potential of liquid biopsy tracking in the posttreatment surveillance of patients with nonmetastatic nasopharyngeal carcinoma

  2020cites this paper
• Proton/heavy ion therapy in salvage of locally recurrent nasopharyngeal carcinoma

  2020cites this paper
• Combination of precision radiotherapy with chemotherapy and immunotherapy in non-recurrent/metastatic nasopharyngeal carcinoma

  2020cites this paper
• Emerging radiotherapy technologies and trends in nasopharyngeal cancer

  2020cites this paper
• Clinical outcomes of carbon‐ion radiotherapy for patients with locoregionally recurrent nasopharyngeal carcinoma

  2020cites this paper
• Pre-treatment FLT-PET parameters as a prognostic tool for patients with locally advanced recurrent nasopharyngeal carcinoma salvaged by carbon-ion radiotherapy: a pilot study

  2020cites this paper
• Comparison of the efficacy and toxicity of postoperative proton versus carbon ion radiotherapy for head and neck cancers

  2020cites this paper
• Volumetric parameters derived from FLT-PET performed at completion of treatment predict efficacy of Carbon-ion Radiotherapy in patients with locally recurrent Nasopharyngeal Carcinoma

  2020cites this paper
• LINAC-based Fractionated Stereotactic Radiotherapy for Residual and Recurrent Nasopharyngeal Carcinoma in the Era of Intensity-modulated Radiotherapy: A 10-year Experience

  2020cites this paper
• Biological Guided Carbon-Ion Microporous Radiation to Tumor Hypoxia Area Triggers Robust Abscopal Effects as Open Field Radiation

  2020cites this paper
• Recurrent Nasopharyngeal Cancer: Critical Review of Local Treatment Options Including Recommendations during the COVID-19 Pandemic

  2020cites this paper
• RBE-weighted dose conversions for patients with recurrent nasopharyngeal carcinoma receiving carbon-ion radiotherapy from the local effect model to the microdosimetric kinetic model

  2020cites this paper
• Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.

  2020cites this paper
• Long‐term monitoring of dynamic changes in plasma EBV DNA for improved prognosis prediction of nasopharyngeal carcinoma

  2020cites this paper
• Carbon Ion Therapy: A Modern Review of an Emerging Technology

  2020cites this paper
• Re-irradiation with protons or heavy ions with focus on head and neck, skull base and brain malignancies.

  2020cites this paper
• CLIC4 regulates radioresistance of nasopharyngeal carcinoma by iNOS after γ-rays but not carbon ions irradiation.

  2020cites this paper
• Particle therapy in head and neck cancer—expanding therapeutic options

  2020cites this paper
• Carbon-ion radiotherapy in the treatment of radiation-induced second primary malignancies

  2020cites this paper
• Nasopharyngeal carcinoma – Improving cure with technology and clinical trials

  2020cites this paper
• Management of recurrent nasopharyngeal carcinoma: current perspectives

  2019cites this paper
• Intensity-modulated carbon-ion radiation therapy versus intensity-modulated photon-based radiation therapy in locally recurrent nasopharyngeal carcinoma: a dosimetric comparison

  2019cites this paper
• Management of locally recurrent nasopharyngeal carcinoma.

  2019cites this paper
• Carbon Ion Re-Irradiation for Recurrent Head-and-Neck Cancer: A Single-Institutional Experience.

  2019cites this paper
• Nasopharyngeal carcinoma.

  2019cites this paper
• CMAR_A_219994 8431..8442

  2019cites this paper
• CMAR_A_205421 7767..7777

  2019cites this paper
• Characteristic And Novel Therapeutic Strategies Of Nasopharyngeal Carcinoma With Synchronous Metastasis

  2019cites this paper
• Pretreatment MRI radiomics analysis allows for reliable prediction of local recurrence in non-metastatic T4 nasopharyngeal carcinoma

  2019cites this paper
• Current Treatment Landscape of Nasopharyngeal Carcinoma and Potential Trials Evaluating the Value of Immunotherapy.

  2019cites this paper
• Clinical Management of Blood–Brain Barrier Disruptions after Active Raster-Scanned Carbon Ion Re-Radiotherapy in Patients with Recurrent Head-and-Neck Cancer

  2019cites this paper
• Bimodal Radiotherapy with Active Raster-Scanning Carbon Ion Radiotherapy and Intensity-Modulated Radiotherapy in High-Risk Nasopharyngeal Carcinoma Results in Excellent Local Control

  2019cites this paper
• Rare entities in head-and-neck cancer: salvage re-irradiation with carbon ions

  2019cites this paper
• Dose-Limiting Organs at Risk in Carbon Ion Re-Irradiation of Head and Neck Malignancies: An Individual Risk-Benefit Tradeoff

  2019cites this paper
• The relative biological effectiveness of proton and carbon ion beams in photon-sensitive and resistant nasopharyngeal cancer cells

  2018cites this paper
• Re-irradiation for recurrent NPC—is the treatment merited at all?

  2018cites this paper
• Progress in research on the treatment of recurrent nasopharyngeal carcinoma

  year unknowninfluential citation